Czech Republic - Medicinal products and medical devices - Medicinal product containing the active substance VORASIDENIB

The contracting authority in the Czech Republic is launching a public procurement procedure for medicinal products. The subject of the tender is the conclusion of a framework purchase agreement for the supply of medicinal products containing the active substance vorasidenib, according to the needs of the contracting authority. Specific quantities will be ordered as required under the framework agreement. Suppliers of medicinal products may participate under the applicable public procurement rules and conditions set out in the tender documentation.

Description

35 open tenders right now

• Medicinal products and medical devices - Medicinal product with active substance ERDAFITINIB 28 Sep 2026 · 1 day left
• Czech Republic - Medicinal products and medical devices - Medicinal products with active substance USTEKINUMAB II. 28 Sep 2026 · 1 day left
• Medicinal products and medical devices - Medicinal product with active substance MOMELOTINIB 28 Sep 2026 · 1 day left

Recent awards

• Česko - Léčivé přípravky a zdravotnické prostředky - Dodávky léčivých přípravků s účinnou látkou Brodalumab

  awarded to Alliance Healthcare s.r.o. €767,543

• Česko - Léčivé přípravky a zdravotnické prostředky - Léčivý přípravek s účinnou látkou AFLIBERCEPT

  awarded to BAYER s.r.o. €1,419,506

• Česko - Opravy a údržba zdravotnických přístrojů - Servisní služby na produkty výrobce Maquet a Getinge

  awarded to Getinge Czech Republic, s.r.o. €141,943

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€10,072,234

9,825 open across Europe right now 71% below sector average

Buyer track record on Aperlena

455 notices tracked · 161 awarded

€340,824,584 in awarded contracts